children, and significance of myringotomy:diagnostic or therapeutic? J Korean MedSci 2004;19:739-43.34. Edwards S, German M, Hughes A,Letts C, Sinka I. Manual RLDS. TheReynell developmental language scales III.Third edition manual windsor: NFER-NELSON Publishing Company Ltd; 1997.35. Eriksson L, Grundström P. Reynelldevelopmental language scales III. Översättningoch normering, samt studieöver sambandet mellan testresultat ochföräldrars utbildningsnivå. Umeå Universitet,Institutionen för klinisk vetenskap,Institutionen för logopedi; 2000.36. Personlig korrespondens med Kari JKvaerner via Anne Pitkäranta, 2006-05-11.37. Personlig korrespondens med JensUlrik Felding, 2006-03-09.38. Personlig korrespondens med AnnePitkäranta, 2006-05-11.39. Schilder A. International perspectiveson management of otitis media. In: Recentadvances in Otitis media. Proc of the 8thinternational symposium. 2003:10-11.40. Derkay CS, Carron JD, Wiatrak BJ,Choi SS, Jones JE. Postsurgical followupof children with tympanostomytubes: results of the American academyof otolaryngology-head and neck surgerypediatric otolaryngology committee nationalsurvey. Otolaryngol Head NeckSurg 2000;122:313-8.41. Lous J, Burton M, JU. F, Ovesen T,Rovers M, Williamson I. Grommets(ventilation tubes) for hearing loss associatedwith otitis media with effusion inchildren. Cochrane Database ofSystematic Reviews 2005, Issue 1. Art.No.: CD001801. DOI: 10.1002/14651858.CD001801.pub2.42. Langton Hewer C, McDonald S, NunezD. Grommets (ventilation tubes) for recurrentacute otitis media in children. (Protocol)Cochrane Database of Systematic Reviews2004, Issue 2. Art. No.: CD004741. DOI:10.1002/14651858.CD004741. CochraneDatabase of Systematic Reviews.43. Drummond M, O’Brien B, StoddartGL, Torrance GW. . Methods for theeconomic evaluation of health care programmes.Second edition. Oxford: OxfordMedical Publications; 1997.44. Gonzalez C, Arnold JE, Woody EA,Erhardt JB, Pratt SR, Getts A, et al.Prevention of recurrent acute otitis media:chemoprophylaxis versus tympanostomytubes. Laryngoscope 1986;96:1330-4.45. Howie VM, Ploussard JH, Sloyer J.The “otitis-prone” condition. Am J DisChild 1975;129:676-8.46. Niemela M, Uhari M, Jounio-ErvastiK, Luotonen J, Alho OP, Vierimaa E. Lackof specific symptomatology in childrenwith acute otitis media. Pediatr InfectDis J 1994;13:765-8.47. Bluestone C. Definitions of otitismedia and related diseases. In: Alper C,Bluestone, CD, Klein, JO, editor. AdvancedTherapy of Otitis Media. Hamilton,Canada: BC Decker; 2004. p 1-8.48. Chan LS, Takata GS, Shekelle P,Morton SC, Mason W, Marcy SM.Evidence assessment of management ofacute otitis media: II. Research gaps andpriorities for future research. Pediatrics2001;108:248-54.204Rörbehandling vid inflammation i mellanörat
49. MacClements JE, Parchman M,Passmore C. Otitis media in children:use of diagnostic tools by family practiceresidents. Fam Med 2002;34:598-603.50. Pichichero ME, Poole MD. Comparisonof performance by otolaryngologists,pediatricians, and general practioners onan otoendoscopic diagnostic video examination.Int J Pediatr Otorhinolaryngol2005;69:361-6.51. Schwartz RH, Rodriguez WJ,McAveney W, Grundfast KM. Cerumenremoval. How necessary is it to diagnoseacute otitis media? Am J Dis Child 1983;137:1064-5.52. Rosenfeld R, Bluestone, CD. Clinicalefficacy of surgical therapy. In: Hamilton,editor. Evidence based otitis media. Hamilton,ON, Canada: BC Decker Inc; 2003.p 227-40.53. Rosenfeld RM. Surgical preventionof otitis media. Vaccine 2000;19 Suppl 1:134-9.54. Le CT, Freeman DW, Fireman BH.Evaluation of ventilating tubes and myringotomyin the treatment of recurrentor persistent otitis media. Pediatr InfectDis J 1991;10:2-11.55. Gebhart DE. Tympanostomy tubes inthe otitis media prone child. Laryngoscope1981;91:849-66.56. Casselbrant ML, Kaleida PH, RocketteHE, Paradise JL, Bluestone CD, Kurs-Lasky M, et al. Efficacy of antimicrobialprophylaxis and of tympanostomy tubeinsertion for prevention of recurrent acuteotitis media: results of a randomized clinicaltrial. Pediatr Infect Dis J 1992;11:278-86.57. Rosenfeld M. Clinical efficacy of medicaltherapy. In: Hamilton, editor. Evidencebased otitis media. Hamilton, ON,Canada: BC Decker Inc; 2003. p 199-226.58. Williams RL, Chalmers TC, StangeKC, Chalmers FT, Bowlin SJ. Use of antibioticsin preventing recurrent acute otitismedia and in treating otitis media witheffusion. A meta-analytic attempt to resolvethe brouhaha. JAMA 1993;270:1344-51.59. Koivunen P, Uhari M, Luotonen J,Kristo A, Raski R, Pokka T, et al. Adenoidectomyversus chemoprophylaxis andplacebo for recurrent acute otitis media inchildren aged under 2 years: randomisedcontrolled trial. BMJ 2004;328:487.60. Liston TE, Foshee WS, Pierson WD.Sulfisoxazole chemoprophylaxis for frequentotitis media. Pediatrics 1983;71:524-30.61. Principi N, Marchisio P, Massironi E,Grasso RM, Filiberti G. Prophylaxis ofrecurrent acute otitis media and middle-eareffusion. Comparison of amoxicillin withsulfamethoxazole and trimethoprim. AmJ Dis Child 1989;143:1414-8.62. Prellner K, Fogle-Hansson M,Jorgensen F, Kalm O, Kamme C. Pre vention of recurrent acute otitis me diain otitis-prone children by inter mittentprophylaxis with penicillin. ActaOtolaryngol 1994;114:182-7.63. Fogle-Hansson M, White P,Hermansson A, Prellner K. Short-termpenicillin-V prophylaxis did not preventacute otitis media in infants. Int J PediatrOtorhinolaryngol 2001;59:119-23.64. Kalm O, Prellner K, Christensen P.The effect of intravenous immunoglobukapitel3 • Resultat av litteraturgranskningen 205
- Page 2 and 3:
SBU utvärderar sjukvårdens metode
- Page 5 and 6:
InnehållSBU:s sammanfattning och s
- Page 7 and 8:
5.1.3 Enkät till öron-näsa-hals-
- Page 9:
SBU:s sammanfattningoch slutsatserS
- Page 12 and 13:
långvarig vätska i mellanörat (E
- Page 14 and 15:
FörekomstAkut och sekretorisk medi
- Page 16 and 17:
MetodikUrval av studierDet vetenska
- Page 18 and 19:
EvidensgraderingDe studier som uppn
- Page 20 and 21:
Är rörbehandling effektivare än
- Page 22 and 23:
Två studier med högt och sju med
- Page 24 and 25:
örbehandling på barn med Downs sy
- Page 26 and 27:
1008060SOMrAOM40200Otoskopi + Siegl
- Page 28 and 29:
Indikationen för rörbehandling vi
- Page 31 and 32:
InledningSedan drygt 50 år tillbak
- Page 33:
1. BakgrundFaktaruta 1 Definitioner
- Page 36:
Hos barn som inte tillfrisknar spon
- Page 41:
De visar på en total samhällsekon
- Page 44 and 45:
Enbart randomiserade studier accept
- Page 47 and 48:
2.4 MetodproblemDe viktigaste probl
- Page 49:
Tidig postoperativ rörflytning har
- Page 52 and 53:
terade studier där barnen haft fä
- Page 54 and 55:
Ytterligare ett alternativ skulle k
- Page 56 and 57:
Två studier med medelhögt bevisv
- Page 58 and 59:
Maw och medarbetare inkluderade 182
- Page 60 and 61:
tagit hänsyn till graden av hörse
- Page 62 and 63:
Sammantaget talar en studie med hö
- Page 64 and 65:
ehandling [101,102]. Acceptansen va
- Page 66 and 67:
Några studier har undersökt effek
- Page 68 and 69:
åtgärd [126]. Detta stöds av en
- Page 70 and 71:
Sexton studier som uppfyllde inklus
- Page 72 and 73:
I Sverige används inte preparat me
- Page 74 and 75:
Tre studier undersökte trumhinnef
- Page 76 and 77:
av övriga trumhinneförändringar
- Page 78 and 79:
• Det finns inte tillräckligt ve
- Page 80 and 81:
adenoidektomi utfördes vid behov.
- Page 82 and 83:
som inte används i Sverige. Samman
- Page 84 and 85:
Table 3.1.1 Effect of ventilation t
- Page 86 and 87:
Table 3.1.2.1 Long-term antibiotics
- Page 88 and 89:
Table 3.1.2.1 continuedAuthorYearRe
- Page 90 and 91:
Table 3.1.2.2 Effect of short-term
- Page 92 and 93:
Table 3.1.2.2 continuedAuthorYearRe
- Page 94 and 95:
Table 3.1.2.3 Effect of pneumococca
- Page 96 and 97:
Table 3.1.2.3 continuedAuthorYearRe
- Page 98 and 99:
Table 3.1.3 Effects of adenoidectom
- Page 100 and 101:
Table 3.1.3 continuedAuthorYearRefe
- Page 102 and 103:
Table 3.2.1 Ventilation tubes compa
- Page 104 and 105:
Table 3.2.1 continuedAuthorYearRefe
- Page 106 and 107:
Table 3.2.1 continuedAuthorYearRefe
- Page 108 and 109:
Table 3.2.1 continuedAuthorYearRefe
- Page 110 and 111:
Table 3.2.1 continuedAuthorYearRefe
- Page 112 and 113:
Table 3.2.2 Effects of ventilation
- Page 114 and 115:
Table 3.2.2 continuedAuthorYearRefe
- Page 116 and 117:
Table 3.2.2 continuedAuthorYearRefe
- Page 118 and 119:
Table 3.2.3.1 Effect of adenoidecto
- Page 120 and 121:
Table 3.2.3.1 continuedAuthorYearRe
- Page 122 and 123:
Table 3.2.3.2 Effects of myringotom
- Page 124 and 125:
Table 3.2.3.2 continuedAuthorYearRe
- Page 126 and 127:
Table 3.2.4 Effects of autoinflatio
- Page 128 and 129:
Table 3.3.1 Ventilation tube types
- Page 130 and 131:
Table 3.3.1 continuedAuthorYearRefe
- Page 132 and 133:
Table 3.3.1 continuedAuthorYearRefe
- Page 134 and 135:
Table 3.3.1 continuedAuthorYearRefe
- Page 136 and 137:
Table 3.3.1 continuedAuthorYearRefe
- Page 138 and 139:
Table 3.3.2 Surgical procedures - e
- Page 140 and 141:
Table 3.3.2 continuedAuthorYearRefe
- Page 142 and 143:
Table 3.3.2 continuedAuthorYearRefe
- Page 144 and 145:
Table 3.3.2 continuedAuthorYearRefe
- Page 146 and 147:
Table 3.3.3 Anaesthetic complicatio
- Page 148 and 149:
Table 3.4.1 Effects of prophylaxis
- Page 150 and 151:
Table 3.4.1 continuedAuthorYearRefe
- Page 152 and 153: Table 3.4.1 continuedAuthorYearRefe
- Page 154 and 155: Table 3.4.1 continuedAuthorYearRefe
- Page 156 and 157: Table 3.4.2 Effect of treatment of
- Page 158 and 159: Table 3.4.2 continuedAuthorYearRefe
- Page 160 and 161: Table 3.4.3 Risk for otorrhea relat
- Page 162 and 163: Table 3.4.3 continuedAuthorYearRefe
- Page 164 and 165: Table 3.5.1 Complications and seque
- Page 166 and 167: Table 3.5.1 continuedAuthorYearRefe
- Page 168 and 169: Table 3.5.1 continuedAuthorYearRefe
- Page 170 and 171: Table 3.5.1 continuedAuthorYearRefe
- Page 172 and 173: Table 3.5.1 continuedAuthorYearRefe
- Page 174 and 175: Table 3.5.1 continuedAuthorYearRefe
- Page 176 and 177: Table 3.5.1 continuedAuthorYearRefe
- Page 178 and 179: Table 3.5.1 continuedAuthorYearRefe
- Page 180 and 181: Table 3.6 Retention and extraction
- Page 182 and 183: Table 3.6 continuedAuthorYearRefere
- Page 184 and 185: Table 3.6 continuedAuthorYearRefere
- Page 186 and 187: Table 3.6 continuedAuthorYearRefere
- Page 188 and 189: Table 3.6 continuedAuthorYearRefere
- Page 190 and 191: Table 3.7.1 Environmental factors i
- Page 192 and 193: Table 3.7.2 Effects of ventilation
- Page 194 and 195: Table 3.7.2 continuedAuthorYearRefe
- Page 196 and 197: Table 3.7.3 Effects of ventilation
- Page 198 and 199: Table 3.8 Economic evaluation studi
- Page 200 and 201: Referenser1. Hermerén G. Riktlinje
- Page 204 and 205: lin treatment in recurrent acute ot
- Page 206 and 207: early surgery versus watchful waiti
- Page 208 and 209: 121. Poetker DM, Lindstrom DR, Pate
- Page 210 and 211: 153. Roland PS, Kreisler LS, Reese
- Page 212 and 213: 183. Praveen CV, Terry RM. Does pas
- Page 214 and 215: 217. Baker RS, Chole RA. A Randomis
- Page 216 and 217: eller fallit ut) blir det vanligen
- Page 219 and 220: 5. PraxisundersökningDet finns ing
- Page 221 and 222: Det vanligaste sättet att diagnost
- Page 223 and 224: Andel ÖNH-specialister5040302010
- Page 225 and 226: 100Rör per 10 000 barn806040200Got
- Page 227 and 228: de mellan 6,5 och 21,5 procent mell
- Page 229: Tabell 5.3 Förväntade kostnader o
- Page 232 and 233: Tabell 6.1 Nytta och risker för ol
- Page 234 and 235: Barn med ökad benägenhet för SOM
- Page 236 and 237: Med modellen som utgångspunkt ser
- Page 238 and 239: Referens1. Hermerén G. Riktlinjer
- Page 240 and 241: Projektet har inte gjort någon sys
- Page 242 and 243: Följderna blir att barn besparas e
- Page 245 and 246: 8. ForskningsbehovTrots att rörbeh
- Page 247: Antal ingående patienter: För en
- Page 250 and 251: MyringotomiNNTOMEOR, odds ratio,ell
- Page 252 and 253:
Systematisk översiktTympanometriTy
- Page 254 and 255:
Marie RydingMedicine doktor, överl
- Page 257 and 258:
Bilaga 1. Diagnostiska metoderSymto
- Page 259 and 260:
I studier, där myringotomi har anv
- Page 261 and 262:
Kombination av metodernaEn kombinat
- Page 263 and 264:
SpråkbedömningDet finns ett stort
- Page 265:
effusion. MRC Multi-centre otitis m
- Page 268 and 269:
Öron-näsa-hals-klinikBarn som haf
- Page 271 and 272:
Bilaga 3. Omgivningsfaktorer för r
- Page 273 and 274:
Tillgång till sjukvård och andra
- Page 275 and 276:
Bilaga 4. Hälsoekonomisk modellana
- Page 277 and 278:
BILAGA 4 • Hälsoekonomisk modell
- Page 279 and 280:
SannolikhetFörväntadkostnadFörv
- Page 281 and 282:
är uppskattningar på en skala mel
- Page 283 and 284:
fler läkarbesök och mer frånvaro
- Page 285 and 286:
Förväntad kostnadParameterVärdeP
- Page 287 and 288:
Angivna kostnader avser år 2006 oc
- Page 289 and 290:
Tabell 1 fortsättningStrategi/utfa
- Page 291 and 292:
Rapporter publicerade av SBUGula ra
- Page 293 and 294:
Smärtor i bröstet: Operation, bal
- Page 295:
Hysterectomy - Ratings of Appropria